mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
-0.16 |
0.0004 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0009 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.001 |